INTERNATIONAL COLLABORATION. S. Sinha Adviser Department of Biotechnology Ministry of Science & Technology Government of India

Size: px
Start display at page:

Download "INTERNATIONAL COLLABORATION. S. Sinha Adviser Department of Biotechnology Ministry of Science & Technology Government of India"

Transcription

1 INTERNATIONAL COLLABORATION S. Sinha Adviser Department of Biotechnology Ministry of Science & Technology Government of India

2 INDIA S ASSETS Strong pool of scientists and engineers >300,000 institutions offer degrees/ diplomas in biosciences/ engineering ~100 medical colleges; ~1700 medical graduates/ yr Indian Biotech Industry $1.3 billion strong Nearly 300 SMEs

3 MEASURES TO PROMOTE INNOVATION R&D Funding Small Business Innovation Research Initiative Phase-I: Grant or loan for highly innovative, early stage pre-proof-of-concept research Phase-II: Soft loan up to Rs 100 cr ($ 2.2 million) for projects that have established proof-of-concept and can get venture capital funding Centres of Excellence Innovation/ technology development centres Basic research in frontier areas of life sciences and biotechnology

4 NEW GENERATION VACCINES Live Attenuated Rotaviral vaccine completes first phase infant trial; safe Recombinant Cholera Phase II clinical trial completed. Efficacy comparable to international candidates Rabies Animal trials completed, proposed for commercialization, Human trials planned Malaria GLP production completed, Preclinical toxicology planned Vi conjugate vaccine GMP & Preclinical Toxicology Japanese Encephalitis transferred, GMP production and preclinical toxicology in progress A new influenza vaccine based on VLP technology (not using eggs) in collaboration with BBIL, Hyderabad and Novovax, USA Tuberculosis Animal studies, Aerosol challenge facilities developed Papilloma virus vaccine R&D Avian Flu - R&D Anthrax in clinical trials Mw for treatment of tuberculosis, in clinical trial

5 DIAGNOSTICS Transferred to the Industries & Launched in the Market Japanese Encephalitis Western Blot for HIV-I & II -HIV/AIDS Naked Eye Agglutination System (NEVA) -HIV/AIDS ELISA- Hepatitis C ELISA- Leishmaniasis ELISA- Filariasis ELISA- Alpha-feto Protein (Pregnant Women) TB Slide, Culture, PCR Transferred, yet to be launched: IgM Mac ELISA -Dengue Japanese Encephalitis West Nile IgM ELISA - Hepatitis A Urine Based ELISA - Reproductive Hormones DBT

6 NEW INSTITUTES PROPOSED TO BE ESTABLISHED Translational Health Science Institute UNESCO Centre for Education, Training & Innovation in Biotechnology Vaccine Research Centre National Institute of Medical Genetics Molecular Diagnostic Centre Institute of Animal Biotechnology National Institute of Marine Biotechnology

7 UNESCO REGIONAL CENTER FOR EDUCATION, TRAINING AND INNOVATION IN BIOTECHNOLOGY FOCUS: To create industry-ready workforce to instill and drive innovation in the country and region. To provide education, training and research with regional focus and global quality Multicultural, global environment

8 UNESCO Centre : Training areas a. Bioengineering. b. Bio-enterprise/ Management in Biotechnology c. Platform technologies d. IPR/technology transfer e. Regulatory procedures f. Biosafety g. Bioethics h. Process development and up-scaling i. Preclinical toxicity and clinical trials j. Good manufacturing practices/good laboratory practices k. Biostatistics and epidemiology

9 UNESCO Centre Research: To support education and training and drive innovation in synergy with the other institutes in the Pan Asian Region. Areas of focus: Bioengineering Nano biology Chronic disease biology

10 UNESCO Centre : International Character Stanford -India Biodesign Programme - Indigenous Production of Biomedical Devices, implants & bio-instruments - Will be co-ordinated from UNESCO Center MOU with Boston University underway Bioengineering ( education, skill development & collaborative research) IPR, Tech. Transfer and Commercialization Others: UCLA etc.

11 Linkages of HST and UNESCO Center Other Stakeholder Entities ICGEB NII Industries AIIMS UNESCO Center THSTI UCLA Boston University IITs Jamia Hamdard Other Stakeholder Entities Stanford Univ.

12 Biotechnology Cluster: a locus for Discovery, Innovation, and Education Translational Health Science Technology Institute UNESCO Center for Biotechnology Education and Research Translational Center Preclinical,clinical and product development in partnership with other stakeholders and industry Health Science Technology Center A multidisciplinary, multiprofessional research and training institute, highly interconnected with regional centers of excellence Academic Council Degree-granting authority Oversee degrees developed by I-HST, UNESCO Academy etc. UNESCO Academy for industry relevant education and training Portfolio of training programs serving the regional workforce needs Research Center Disciplinary research efforts in mission-critical areas Nanoscience and Technology Unit Research Resources Animal Facility Library Auditorium Technology/ Scientific platform Large scale sequencing Genetic analysis Proteomics RNAi Imaging Chemical Biology Bio Banks

13 Indo-Norwegian Collaboration in Vaccination Research Goals: Development of new candidate vaccines Identification of optimal formulations and immunization regimens for new and available vaccines Increased availability and equitable coverage of existing vaccines Identification of surrogate markers of vaccine-induced protection Development of improved strategies for cost-effective production of vaccines

14 Development of sustainable health systems with incorporated well-functioning routines for vaccination of population groups Contributions to more efficient use of existing vaccines, (including studies of total health effects of current vaccination programmes in different populations) Development of well-functioning international cooperation and cross-disciplinary vaccination research that includes Norwegian research groups

15 INTERNATIONAL COLLABORATION NEW INITIATIVES COUNTRY RESEARCH AREAS OF COLLABORATION Denmark Medical Biotechnology : Stem cell research; chronic and infectious diseases Agriculture biotechnology Environmental biotechnology. Finland Vaccine development and technologies Development of new innovative diagnostics u Computational biology related to drug development. Germany Agreement for collaboration in all areas of biotechnology The Netherlands Tailored biotechnologies for social needs including traditional biotechnology and genomics. Norway Development of human, fish and animal vaccines Switzerland Converting research leads into products and processes of social and economic value with a focus in agriculture biotechnology. United Kingdom Agricultural biotechnology research Other areas also considered United States of America Vaccine Development Programme Contraceptive Research and Reproductive Health Agriculture Biotechnology Vision Research

16 Thank You!

INDIA PUBLIC: PRIVATE PARTNERSHIP MODELS FOR R&D (INFECTIOUS DISEASES) OPPORTUNITIES AND CONSTRAINTS

INDIA PUBLIC: PRIVATE PARTNERSHIP MODELS FOR R&D (INFECTIOUS DISEASES) OPPORTUNITIES AND CONSTRAINTS PUBLIC: PRIVATE PARTNERSHIP MODELS FOR R&D (INFECTIOUS DISEASES) OPPORTUNITIES AND CONSTRAINTS Prof. V.K.Vinayak Senior Advisor Department of Biotechnology Ministry of Science & Technology Block # 2, CGO

More information

Promoting Women in Science

Promoting Women in Science Promoting Women in Science Initiatives of Department of Biotechnology Department of Biotechnology Ministry of Science & Technology Government of India Department of Biotechnology Set up in 1986 Focus Research

More information

ZIKAVAX PARTNERSHIP. Dr Odile LEROY DCVMN Seoul 26 th September 2017

ZIKAVAX PARTNERSHIP. Dr Odile LEROY DCVMN Seoul 26 th September 2017 ZIKAVAX PARTNERSHIP Dr Odile LEROY DCVMN Seoul 26 th September 2017 1 Product Development Partnership THE EUROPEAN VACCINE INITIATIVE IS A PRODUC T DEVELOPMENT PARTNERSHIP WHICH AIMS TO ACCELERATE THE

More information

BIO OUTSOURCING ASIA Biopharmaceutical Outsourcing Opportunities and Challenges SEPTEMBER 2008 VOL. 1 ISSUE 3

BIO OUTSOURCING ASIA Biopharmaceutical Outsourcing Opportunities and Challenges SEPTEMBER 2008 VOL. 1 ISSUE 3 BIO OUTSOURCING ASIA Biopharmaceutical Outsourcing Opportunities and Challenges SEPTEMBER 2008 VOL. 1 ISSUE 3 Bio Outsourcing Asia TABLE OF CONTENTS September 2008 Vol. 1 Issue 3 CanBiotech Inc. CHINA

More information

The Seventh Framework Programme ( )

The Seventh Framework Programme ( ) The Seventh Framework Programme (2007-2013) Opportunities for Cardiovascular Research 1 Octavi Quintana Trias, MD, MPH Director Health DG Research - European Commission Octavi.Quintana-Trias@ec.europa.eu

More information

EU support for Health Research from FP6 to FP7

EU support for Health Research from FP6 to FP7 EU support for Health Research from FP6 to FP7 Stéphane Hogan Head of Biotechnology Unit Directorate for Health Research DG Research - European Commission Valencia - 15 September 2006 EU research programmes

More information

Introduction of Development Center for Biotechnology TAIWAN

Introduction of Development Center for Biotechnology TAIWAN Introduction of Development Center for Biotechnology TAIWAN DCB Nonprofit Organization Founded in 1984 Funded Mainly by Ministry of Economic Affairs (MOEA), National Science Council and the Industry 394

More information

Celebrating 30 years of Department of Biotechnology (DBT)

Celebrating 30 years of Department of Biotechnology (DBT) Celebrating 30 years of Department of Biotechnology (DBT) Professor Vijay K. Chaudhary Dr. Amita Gupta Department of Biochemistry University of Delhi South Campus New Delhi-110021 1 Swachhta (Cleanliness)

More information

2017 Call for Proposals EDCTP-TDR Clinical Research and Development Fellowships

2017 Call for Proposals EDCTP-TDR Clinical Research and Development Fellowships 2017 Call for Proposals EDCTP-TDR Clinical Research and Development Fellowships Call Identifier: TMA2017IF The purpose of this Call for Proposals is to provide funding towards actions that aim to support

More information

National Institute of Virology(NIV), Pune

National Institute of Virology(NIV), Pune National Institute of Virology(NIV), Pune Japanese Encephalitis Vaccine Product/Process: Chimeric peptide vaccine candidate against Japanese Encephalitis virus. Application/Uses: Japanese encephalitis

More information

+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA

+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA At the Center for Infectious Disease Research, we use systems biology approaches and cutting-edge technologies to accelerate the development of life-saving drugs, diagnostics and treatments for the world

More information

IVI and Technology Transfer. 14 th DCVMN Meeting Hanoi, October 7-9, 2013

IVI and Technology Transfer. 14 th DCVMN Meeting Hanoi, October 7-9, 2013 IVI and Technology Transfer 14 th DCVMN Meeting Hanoi, October 7-9, 2013 5 17 months: 46% - 27% - 18 months 6-12 weeks: 27% - 15 % 86 / 78% IVI Vision & Mission VISION Developing countries free of suffering

More information

DBT-IIT Workshop. IIT Bombay Presentation. by Prof. Dulal Panda

DBT-IIT Workshop. IIT Bombay Presentation. by Prof. Dulal Panda DBT-IIT Workshop IIT Bombay Presentation by Prof. Dulal Panda 1 Research & Development 2 Faculty involved in Bio-research 15% faculty of institute actively involved in bio-research A wide-spectrum from

More information

Malaria Research Capability Strengthening in Africa

Malaria Research Capability Strengthening in Africa July 2005 UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) Multilateral Initiative on Malaria (MIM) Malaria Research Capability Strengthening in Africa INTRODUCTION

More information

SingHealth and A*STAR to advance medical research in diabetes; immunotherapy and drug development; and precision medicine

SingHealth and A*STAR to advance medical research in diabetes; immunotherapy and drug development; and precision medicine MEDIA RELEASE SingHealth and A*STAR to advance medical research in diabetes; immunotherapy and drug development; and precision medicine Strategic partnership sees Singapore s largest public healthcare

More information

Malaria Research Capability Strengthening in Africa

Malaria Research Capability Strengthening in Africa October 2004 UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) Multilateral Initiative on Malaria (MIM) Malaria Research Capability Strengthening in Africa

More information

Developing Vaccines for Neglected Diseases

Developing Vaccines for Neglected Diseases Developing Vaccines for Neglected Diseases Vaccine Technologies II Albufeira, Portugal June 5 th, 2008 Douglas Holtzman, Ph.D., M.P.H. Senior Program Officer, Global Health Program Bill & Melinda Gates

More information

The Integrated Biomedical Sciences Graduate Program

The Integrated Biomedical Sciences Graduate Program The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to

More information

A unique Collaborative Model for the Discovery of New Therapeutic Approaches

A unique Collaborative Model for the Discovery of New Therapeutic Approaches A unique Collaborative Model for the Discovery of New Therapeutic Approaches THE INNOVATION GAP OPEN INNOVATION TO ADDRESS THE LACK OF PRODUCTIVITY OF BIOPHARMACEUTICAL RESEARCH A PRE-COMPETITIVE PHARMA

More information

Setting the stage: Privacy, security, regulation, and voluntary data sharing within Precision Medicine

Setting the stage: Privacy, security, regulation, and voluntary data sharing within Precision Medicine and Personalized Medicine Setting the stage: Privacy, security, regulation, and voluntary data sharing within UCSF Mini-Medical School November 7, 2013 Claire D. Brindis, Dr. P.H. Director, Philip R. Lee

More information

Biomedical Research on Human Participants

Biomedical Research on Human Participants Ethical Guidelines for Biomedical Research on Human Participants Dr P Paul Kumaran MBBS, BA (Psychology), MPH Scientist E [Deputy Director Medical] National Institute for Research in Tuberculosis (ICMR)

More information

Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend

Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend Dr. dr. Francisca Srioetami Tanoerahardjo, SpPK., MSi Essential Practical Molecular Diagnostics Seminar Hotel

More information

Vacancy: DBT BMGF BIRAC, Program Management Unit at BIRAC, New Delhi, India.

Vacancy: DBT BMGF BIRAC, Program Management Unit at BIRAC, New Delhi, India. Biotechnology Industry Research Assistance Council (A Govt. of India Enterprise) Set up by Department of Biotechnology, Ministry of Science & Technology, Govt. of India Vacancy: DBT BMGF BIRAC, Program

More information

Centro de Pesquisas Gonçalo Moniz / Gonçalo Moniz Research Center. Fiocruz-Bahia. July, 2013

Centro de Pesquisas Gonçalo Moniz / Gonçalo Moniz Research Center. Fiocruz-Bahia. July, 2013 Centro de Pesquisas Gonçalo Moniz / Gonçalo Moniz Research Center Fiocruz-Bahia July, 2013 Oswaldo Cruz Foundation 1900-2013 Research Education Innovation and Production Reference Services Information

More information

Step-by-Step Description of ELISA

Step-by-Step Description of ELISA Step-by-Step Description of ELISA The protocols in this kit rely on indirect antibody capture ELISA. The steps in this assay are: Step 1: Antigen is added to the wells of the microplate strip and incubated

More information

Hannover, your first foothold for business expansion into Europe

Hannover, your first foothold for business expansion into Europe Hannover, your first foothold for business expansion into Europe Hannover Clinical Trial Center & hannoverimpuls Support for entering the health care market 1 The Hannover Region features all important

More information

Nanotechnology and Advanced Materials for more effective Healthcare

Nanotechnology and Advanced Materials for more effective Healthcare Nanotechnology and Advanced Materials for more effective Healthcare This challenge taps into the potential of nanotechnologies and advanced materials to enable more effective therapies and diagnostics

More information

Government s role in developing solutions for diseases that disproportionately affect developing countries

Government s role in developing solutions for diseases that disproportionately affect developing countries Government s role in developing solutions for diseases that disproportionately affect developing countries Diran Makinde NEPAD: West Africa Biosciences Network Dakar, Senegal Luncheon Seminar: From Biotechnology

More information

Webinar IMI2 Call 14 Opportunities for SMEs

Webinar IMI2 Call 14 Opportunities for SMEs Webinar IMI2 Call 14 Opportunities for SMEs 19 March 2018 Agenda How to use GoToWebinar Catherine Brett, IMI Opportunities for SMEs Colm Carroll, IMI Questions & answers How to use GoToWebinar - audio

More information

Opportunities for industry/smes in EU-funded health research

Opportunities for industry/smes in EU-funded health research Opportunities for industry/smes in EU-funded health research Stéphane Hogan, M.Sc, MBA Head of Unit Applied Genomics and Biotechnology for Health DG Research - European Commission 1 Paris, 31 May 2005

More information

10. BIOTECHNOLOGY (Code No. 045)

10. BIOTECHNOLOGY (Code No. 045) 10. BIOTECHNOLOGY (Code No. 045) An unprecedented growth of human knowledge in the field of Biological Sciences coupled with equally significant developments in the field of technology have brought significant

More information

Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre

Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Bryan Williams MD FRCP FESC FAHA Professor of Medicine and BRC Director 29/08/2013 Creating

More information

Konica Minolta to Acquire Invicro (US)

Konica Minolta to Acquire Invicro (US) Konica Minolta to Acquire Invicro (US) Acceleration of expansion of precision medicine business Offering new value for drug discovery and development in immuno-oncology and neurodegenerative disease September

More information

University of the Philippines

University of the Philippines University of the Philippines Groundbreaking of the Philippine Genome Center Building April 10, 2014 Launch of the Core Facility for Bioinformatics April 14, 2014 SCIENTIFIC SYMPOSIUM Genomics: The Path

More information

Section I: Pharmaceuticals and Medical Devices

Section I: Pharmaceuticals and Medical Devices SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical

More information

PHARMACEUTICAL INDUSTRIES IN TOYAMA

PHARMACEUTICAL INDUSTRIES IN TOYAMA PHARMACEUTICAL INDUSTRIES IN TOYAMA Profile(outline of Toyama Prefecture) Toyama prefecture is located near the center of Japan and is approximately the same distance from the three largest cities in Japan-Tokyo,Nagoya,and

More information

ATIP Avenir Program 2018 Young group leader

ATIP Avenir Program 2018 Young group leader ATIP Avenir Program 2018 Young group leader Important dates - October 17th (4 pm) 2017 : opening of the registrations online - November 23 th 2017: deadline for the online submission, the mailing of the

More information

New Horizons for TB Vaccine Research

New Horizons for TB Vaccine Research New Horizons for TB Vaccine Research IJmuiden, 10 February 2015 Line MATTHIESSEN, MD, PhD Head of Unit - 'Fighting infectious diseases and global epidemics, Health Directorate Directorate-General for Research

More information

Development Stage of Therapeutic Vaccines: The Regulator s View

Development Stage of Therapeutic Vaccines: The Regulator s View Development Stage of Therapeutic Vaccines: The Regulator s View Thomas Hinz Head, Section Therapeutic Vaccines Paul Ehrlich Institute, Germany thomas.hinz@pei.de 1 DISCLAIMER This is the personal views

More information

KRISANI BIO SCIENCES PVT. LTD.

KRISANI BIO SCIENCES PVT. LTD. KRISANI BIO SCIENCES PVT. LTD. Flat B2, 2 nd Floor, Suryateja Apartments, Hindi Nagar, Punjagutta, Hyderabad, Telangana 500078. Email: kkr@krisanibio.com. URL: www.krisanibio.com Contact Number: +91 98494

More information

IMI2: Strategic research agenda and overall approach Hugh Laverty Senior Scientific Project Manager

IMI2: Strategic research agenda and overall approach Hugh Laverty Senior Scientific Project Manager IMI2: Strategic research agenda and overall approach Hugh Laverty Senior Scientific Project Manager Introducing IMI2: Vienna 16 July 2014 The way in which pharmaceutical companies develop new medicines

More information

SPEED UP YOUR TIME TO MARKET

SPEED UP YOUR TIME TO MARKET SPEED UP YOUR TIME TO MARKET #Pre-clinical #Biologics #Small molecules Welcome to Accelera. As a Contract Research Organization (CRO) serving since more than 30 years pharmaceutical and biotechnology companies

More information

Microbial Biotechnology agustin krisna wardani

Microbial Biotechnology agustin krisna wardani Microbial Biotechnology agustin krisna wardani 1. The Structure of Microbes Microbes (microorganisms) are tiny organisms that are too small to be seen individually by the naked eye and must be viewed with

More information

NATIONAL INSTITUTE OF ANIMAL BIOTECHNOLOGY (NIAB)

NATIONAL INSTITUTE OF ANIMAL BIOTECHNOLOGY (NIAB) Advertisement No 1/2014 NATIONAL INSTITUTE OF ANIMAL BIOTECHNOLOGY (NIAB) (An Autonomous Institute of the Dept. of Biotechnology, Ministry of Science & Technology, Government of India) D. No. 1-121/1,

More information

Research Capacity Strengthening

Research Capacity Strengthening Research Capacity Strengthening 2002-2005 UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) Research Capacity Strengthening UNDP/World Bank/WHO Special Programme

More information

INVESTMENT ON PHARMACEUTICALS: THE VIEW OF MINISTRY OF HEALTH

INVESTMENT ON PHARMACEUTICALS: THE VIEW OF MINISTRY OF HEALTH INVESTMENT ON PHARMACEUTICALS: THE VIEW OF MINISTRY OF HEALTH Dra. SRI INDRAWATY, Apt.,M.Kes. Director General of Pharmaceutical Service and Medical Device PRESENTED ON : EU-INDONESIA BUSSINESS DIALOGUE

More information

HOW TO CREATE AN ENTRY-LEVEL CERTIFICATE FROM CORE BIOSCIENCE SKILL STANDARDS NATIONAL CAREER PATHWAYS NETWORK ANNUAL CONFERENCE

HOW TO CREATE AN ENTRY-LEVEL CERTIFICATE FROM CORE BIOSCIENCE SKILL STANDARDS NATIONAL CAREER PATHWAYS NETWORK ANNUAL CONFERENCE HOW TO CREATE AN ENTRY-LEVEL CERTIFICATE FROM CORE BIOSCIENCE SKILL STANDARDS NATIONAL CAREER PATHWAYS NETWORK ANNUAL CONFERENCE Linnea Fletcher, AC2 Regional Bio-Link Center Jeanette Mowery, Bio-Link,

More information

Perspective on China and India as Rapidly Evolving Sources of Biotech Products

Perspective on China and India as Rapidly Evolving Sources of Biotech Products Perspective on China and India as Rapidly Evolving Sources of Biotech Products The Japanese Biologics Forum February 16, 2007 Gene Murano, Ph.D. Vice President R.Q.C. Strategic Operations Genentech, Inc.

More information

SMEs in IMI2 Calls for Proposals

SMEs in IMI2 Calls for Proposals SMEs in IMI2 Calls for Proposals Why should an SME participate in an IMI project? IMI projects are focused on translating excellent research into real world outcomes an opportunity for SMEs Unique collaborative

More information

Molecular Diagnostics

Molecular Diagnostics Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

More information

Main Content Domain % of Operational Items # of Operational Items

Main Content Domain % of Operational Items # of Operational Items The PCOA content areas and subtopics for the 2016-2017 administration are based upon the outcomes from the US College of Pharmacy Curricula Survey. The assessment is composed of four content areas that

More information

REIMAGINING DRUG DEVELOPMENT:

REIMAGINING DRUG DEVELOPMENT: Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY

More information

Singapore offers attractive

Singapore offers attractive Singapore Biotech Guide 2008/2009 Singapore s Biomedical Sciences Landscape companies with spin offs to Singapore, while BMRC takes the lead in coordinating and funding public sector and academic research,

More information

SMEs in IMI2 Calls for Proposals

SMEs in IMI2 Calls for Proposals SMEs in IMI2 Calls for Proposals Why should an SME participate in an IMI project IMI projects are focused on translating excellent research into real world outcomes an opportunity for SMEs Unique collaborative

More information

Shop No.89, 1 st floor, Old Rajinder Nagar, New Delhi DAY REVISION PROGRAM DAY-15

Shop No.89, 1 st floor, Old Rajinder Nagar, New Delhi DAY REVISION PROGRAM DAY-15 IAS BEE Shop No.89, 1 st floor, Old Rajinder Nagar, New Delhi 110060 91-7330833391 40- DAY REVISION PROGRAM DAY-15 1. Consider the following three parent babies recently in news: 1) The resulting child

More information

Healthy Ageing. From Basic Science to Clinical Applications and New Business. Jan Sikkema Center for Development and Innovation June 16, 2016

Healthy Ageing. From Basic Science to Clinical Applications and New Business. Jan Sikkema Center for Development and Innovation June 16, 2016 Healthy Ageing From Basic Science to Clinical Applications and New Business Jan Sikkema Center for Development and Innovation June 16, 2016 Groningen Broad Research University 11 faculties > 30.000 students

More information

TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT

TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT Specialist in tissue analysis by Histology, Immunohistochemistry and In Situ Hybridization TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT CONTENTS Histalim: who we are Our areas of expertise

More information

PACING Guide SY Timeline & Resources Q1 Lesson 1.1 The Mystery Infection

PACING Guide SY Timeline & Resources Q1 Lesson 1.1 The Mystery Infection Ganado Unified School District (PLTW MEDICAL INTERVENTIONS /11-12) ALL INFORMATION TAKEN DIRECTLY FROM PLTW COURSE MATERIAL AS POSTED ON THE MI ONLINE CURRICULUM PACING Guide SY 2017-2018 Timeline & Q1

More information

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA )

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA ) Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA ) Area 1.0 Basic Biomedical Sciences (10%) Area 2.0 Pharmaceutical Sciences (33%) Area 3.0 Social/Behavioral/Administrative Sciences (22%)

More information

Optimisation de votre programme de développement

Optimisation de votre programme de développement Optimisation de votre programme de développement Cedric Lamy, PhD. Cedric.lamy@crl.com Charles River Overview 65-year history: Founded in 1946, publicly traded (NYSE:CRL) Investment in skilled staff: ~7,500

More information

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations Audrey Chang, PhD, Senior Director Development Services Definition of Biologics: PHS Act, section 351 Virus, therapeutic

More information

Computational Drug Discovery

Computational Drug Discovery Computational Drug Discovery Guha. January 10, 2006 Two Revolutions Guha. January 10, 2006 A Corpse in the Alps Why interesting? His Possessions Search for Drugs Not New Traditional Chinese medicine and

More information

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA Dr. Henry Daniell Pegasus Professor & University Board of Trustee Chair Dept. Mol.

More information

Personalized. Health in Canada

Personalized. Health in Canada Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute

More information

Research Assistant (Complex Trait Genomics)

Research Assistant (Complex Trait Genomics) POSITION DESCRIPTION Position Title: Research Assistant (Complex Trait Genomics) Organisation Unit: Institute for Molecular Bioscience Position Number: 3026880 Type of Employment: Full time, fixed term

More information

Biotechnology Cluster Progress Report. of The Santa Fe Plan The Cluster Approach to Economic Gardening

Biotechnology Cluster Progress Report. of The Santa Fe Plan The Cluster Approach to Economic Gardening Biotechnology Cluster Progress Report of The Santa Fe Plan The Cluster Approach to Economic Gardening Prepared by Santa Fe Economic Development, Inc. March, 2000 Executive Summary Santa Fe Economic Development,

More information

A drug development crossroad lies ahead

A drug development crossroad lies ahead G L O B A L C B O C O S T E F F E C T I V E B I O A N A L Y T I C A L H I G H Q U A L I T Y E A R L Y S T A G E C L I N I C A L T R A N S L A T I O N A L M E D I C I N E H I G H L Y C O M P E T E N T A

More information

Prepublication Subject to Further Editorial Correction A-1 appendixa.doc 10/24/ :46 PM. A. Biotechnology

Prepublication Subject to Further Editorial Correction A-1 appendixa.doc 10/24/ :46 PM. A. Biotechnology Prepublication Subject to Further Editorial Correction A-1 A. Biotechnology A Biotechnology A-1 A.1 A Short History of Biotechnology A-1 A.2 Biology Today and Tomorrow A-2 A.3 Bioinformatics, Computational

More information

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.

More information

Curriculum Vitae. Mahina Tabassum Mitul. Contact Number:

Curriculum Vitae. Mahina Tabassum Mitul. Contact Number: Curriculum Vitae Mahina Tabassum Mitul Contact Number: 01779010515 E-mail: mahina18@gmail.com Academic Qualification: Degree University/ Board Major/Concentration Passing Year MS University of Dhaka Biochemistry

More information

LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES

LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES Francesca Pasinelli Direttore Generale 3 Congresso Nazionale SIFaCT Roma, 9 ottobre 2015 About Telethon Fondazione Telethon is

More information

FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)

FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du) FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du) Course BIOMARKERS AND ASSAY DEVELOPMENT February 6-10, 2017 Faculty of Pharmacy Amphitheatre B Universidade de Lisboa, Portugal The FCT

More information

Recombinant Antibody Production in Therapeutic Antibody Projects. Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016

Recombinant Antibody Production in Therapeutic Antibody Projects. Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016 Recombinant Antibody Production in Therapeutic Antibody Projects Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016 Presentation Outline 1 2 3 4 5 Introduction Recombinant Ab Production

More information

New Regulatory Paradigms For Biologicals & Vaccines - an industry perspective

New Regulatory Paradigms For Biologicals & Vaccines - an industry perspective New Regulatory Paradigms For Biologicals & Vaccines - an industry perspective ICDRA Pre-Meeting April 2, 2006 Elaine C. Esber, MD Chair, IFPMA Biologicals and Vaccines Committee Outline IFPMA - representing

More information

WAVA Update to LSDF Board

WAVA Update to LSDF Board WAVA Update to LSDF Board December 7, 2010 Larry Corey WAVA Science Director Incoming President of the Fred Hutchinson Cancer Center Harlan Patterson WAVA Executive Director 1 Washington Vaccine Alliance

More information

Transgenic plants: A new biopharmaceutical manufacturing platform

Transgenic plants: A new biopharmaceutical manufacturing platform Transgenic plants: A new biopharmaceutical manufacturing platform Rachel K. Chikwamba 1, Hugh S. Mason 1, Richard Mahoney 2 and Charles J. Arntzen 1 1 - Center for Infectious Disease and 2 - Vaccinology

More information

Legal Digest. Biosafety Laws Or Guidelines. An online repository of various articles published by our lawyers. February 2001 Rajah & Tann

Legal Digest. Biosafety Laws Or Guidelines. An online repository of various articles published by our lawyers. February 2001 Rajah & Tann An online repository of various articles published by our lawyers Biosafety Laws Or Guidelines 1 Rajah & Tann 4 Battery Road #26-01 Bank of China Building Singapore 049908 Tel: 65 6535 3600 Fax: 65 6538

More information

Dengue Hemorrhagic Fever: A Model for International Collaboration

Dengue Hemorrhagic Fever: A Model for International Collaboration Dengue Hemorrhagic Fever: A Model for International Collaboration Prida Malasit, MD., FRCP Medical Molecular Biology Unit Siriraj Hospital, Faculty of Medicine, Mahidol University, Thailand Dengue Hemorrhagic

More information

SURVEILLANCE AND LABORATORY DIAGNOSTICS OF INFECTIOUS DISEASES IN THE RUSSIAN FEDERATION I. DYATLOV

SURVEILLANCE AND LABORATORY DIAGNOSTICS OF INFECTIOUS DISEASES IN THE RUSSIAN FEDERATION I. DYATLOV SURVEILLANCE AND LABORATORY DIAGNOSTICS OF INFECTIOUS DISEASES IN THE RUSSIAN FEDERATION FEDERAL SERVICE OF SURVAILLANCE IN THE FIELD OF CONSUMER RIGHT PROTECTION & HUMAN WELFARE, RUSSIA I. DYATLOV Russia

More information

Understand biotechnology in livestock animals. Objective 5.04

Understand biotechnology in livestock animals. Objective 5.04 Understand biotechnology in livestock animals. Objective 5.04 Biotechnology and Ethical Issues Biotechnology- technology concerning the application of biological and engineering techniques to microorganisms,

More information

BSc BIOMEDICAL SCIENCE

BSc BIOMEDICAL SCIENCE Overview College of Science Biomedical Science Core March 2017 (1) BSc BIOMEDICAL SCIENCE Biomedical Science Degree 2015 1 College of Science, NUI Galway Fullscreen Next page Overview [60 credits] [60

More information

Biosafety and the NIH Guidelines

Biosafety and the NIH Guidelines Biosafety and the NIH Guidelines This section will explore: Why the NIH Guidelines are important The definition of recombinant or synthetic nucleic acid research Content of the NIH Guidelines Section III

More information

Research and development case study. Human health research

Research and development case study. Human health research Research and development case study Human health research November 2017 Introduction This case study on human health research is one of a series that we have developed to support and complement our published

More information

Technology and Innovation are driving change in the pharmaceutical industry Stefan Krauß Business Segment Pharmaceuticals, Siemens AG

Technology and Innovation are driving change in the pharmaceutical industry Stefan Krauß Business Segment Pharmaceuticals, Siemens AG Technology and Innovation are driving change in the pharmaceutical industry Stefan Krauß Business Segment Pharmaceuticals, Siemens AG Realize innovation. Page 1 MindSphere + Video Digitalization changes

More information

Pharmaceutical Industries

Pharmaceutical Industries Taiwan Biotech and the Pharmaceutical Industries Chei-Hsiang Chen, Ph.D. Director, Biotechnology and Pharmaceutical Industries Program Office, Ministry of Economic Affairs, Taiwan The government has a

More information

Organizing committee at imed.ulisboa/ffulisboa Joao Goncalves (Coordinator) and Paula Brito.

Organizing committee at imed.ulisboa/ffulisboa Joao Goncalves (Coordinator) and Paula Brito. PhD Programme in Medicines and Pharmaceutical Innovation Course BioPharmaceuticals and Advanced Therapies Lisbon, 18, 19, 20 and 25, 26 September 2017 Faculty of Pharmacy Amphitheatre B Universidade de

More information

DISCOVERY AND VALIDATION OF TARGETS AND BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMICS. September, 2011

DISCOVERY AND VALIDATION OF TARGETS AND BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMICS. September, 2011 DISCOVERY AND VALIDATION OF TARGETS AND BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMICS September, 2011 1 CAPRION PROTEOMICS Leading proteomics-based service provider - Biomarker and target discovery

More information

WORK PROGRAMME 2008 COOPERATION THEME 1 HEALTH. (European Commission C(2007)5765 of 29 November 2007)

WORK PROGRAMME 2008 COOPERATION THEME 1 HEALTH. (European Commission C(2007)5765 of 29 November 2007) WORK PROGRAMME 2008 COOPERATION THEME 1 HEALTH (European Commission C(2007)5765 of 29 November 2007) Cooperation Work Programme: Health Theme This work programme replaces the version adopted on 11 June

More information

Horizon 2020 Health Summit-IIS La Fe. Valencia, 12 de diciembre de 2017

Horizon 2020 Health Summit-IIS La Fe. Valencia, 12 de diciembre de 2017 Horizon 2020 Health Summit-IIS La Fe Valencia, 12 de diciembre de 2017 2 History 3 AsphaTeam +75 members Consultants with Life Science Background 20 team members with PhD High knowhow in drug development

More information

The Aptuit Center for Drug Discovery & Development Verona, Italy

The Aptuit Center for Drug Discovery & Development Verona, Italy The Aptuit Center for Drug Discovery & Development Verona, Italy 2 The Aptuit Center for Drug Discovery & Development Verona, Italy Aptuit in Verona: uncommon expertise, exceptional results A knowledgeable

More information

A gateway to academic excellence for Biotech and Pharma

A gateway to academic excellence for Biotech and Pharma A gateway to academic excellence for Biotech and Pharma 6 8 12 Connecting meaningful endpoints: Ksilink s comprehensive translational effort Ksilink s patient centered, translational technology Engaging

More information

Molecular Diagnostics at the Point of Need

Molecular Diagnostics at the Point of Need Molecular Diagnostics at the Point of Need 24 November 2016 David Budd CEO d.budd@genedrive.com 1 DOCUMENT INFORMATION The information contained in this document and made verbally to you (together the

More information

Investigating Clinical Trial Costs Comparative Analysis of Trial Cost Components in Key Geographies Table of Contents

Investigating Clinical Trial Costs Comparative Analysis of Trial Cost Components in Key Geographies Table of Contents Investigating Clinical Trial Costs Comparative Analysis of Trial Cost Components in Key Geographies Table of Contents Executive summary 14 Introduction and background to clinical trials 14 Financial considerations

More information

sirna Overview and Technical Tips

sirna Overview and Technical Tips 1 sirna Overview and Technical Tips 2 CONTENTS 3 4 5 7 8 10 11 13 14 18 19 20 21 Introduction Applications How Does It Work? Handy Tips Troubleshooting Conclusions Further References Contact Us 3 INTRODUCTION

More information

The Right Molecules. Designed. Delivered.

The Right Molecules. Designed. Delivered. The Right Molecules. Designed. Delivered. 400+ Worldwide Clients 80+ Medicinal Chemistry Programs 20+ Preclinical Candidates Delivered Since 2008 10+ In IND Stage 5 Entered Phase I Clinical Trials 2 Entered

More information

USAID DELIVER PROJECT Final Country Report. Indonesia

USAID DELIVER PROJECT Final Country Report. Indonesia USAID DELIVER PROJECT Final Country Report Indonesia USAID DELIVER PROJECT Final Country Report Indonesia USAID DELIVER PROJECT, Task Order 4 The USAID DELIVER PROJECT, Task Order 4, is funded by the

More information